MX159928A - PROCEDURE FOR COATING DRUGS - Google Patents

PROCEDURE FOR COATING DRUGS

Info

Publication number
MX159928A
MX159928A MX8264A MX826485A MX159928A MX 159928 A MX159928 A MX 159928A MX 8264 A MX8264 A MX 8264A MX 826485 A MX826485 A MX 826485A MX 159928 A MX159928 A MX 159928A
Authority
MX
Mexico
Prior art keywords
coating
medicament
sustained release
procedure
composition
Prior art date
Application number
MX8264A
Other languages
Spanish (es)
Inventor
Paul Jonathan Harrison
John Richard Langridge
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of MX159928A publication Critical patent/MX159928A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Abstract

A pharmaceutical composition of a medicament, such as a 5-(pyridinyl)-2(IH) pyridone, in sustained release unit dosage form for oral administration. The composition is in the form of beads within a capsule of gelatin or the like. Each bead comprises an inert particulate core having adhered thereto a coating of particles of the medicament. This coating is in turn surrounded by a sustaining coating of three different polymers with different solubility profiles to allow a sustained release of the medicament both in the low pH environment of the stomach and at a higher pH values prevailing in the intestine.
MX8264A 1984-06-04 1985-06-04 PROCEDURE FOR COATING DRUGS MX159928A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848414220A GB8414220D0 (en) 1984-06-04 1984-06-04 Medicaments in unit dose form

Publications (1)

Publication Number Publication Date
MX159928A true MX159928A (en) 1989-10-06

Family

ID=10561912

Family Applications (1)

Application Number Title Priority Date Filing Date
MX8264A MX159928A (en) 1984-06-04 1985-06-04 PROCEDURE FOR COATING DRUGS

Country Status (20)

Country Link
US (1) US4806361A (en)
EP (1) EP0164959B1 (en)
JP (1) JPS611614A (en)
KR (1) KR920004094B1 (en)
AT (1) ATE73323T1 (en)
AU (1) AU573006B2 (en)
CA (1) CA1258232A (en)
DE (1) DE3585560D1 (en)
DK (1) DK164259C (en)
ES (1) ES8608863A1 (en)
FI (1) FI87990C (en)
GB (1) GB8414220D0 (en)
GR (1) GR851356B (en)
IL (1) IL75403A (en)
MX (1) MX159928A (en)
NO (1) NO166063C (en)
NZ (1) NZ212268A (en)
PH (1) PH24225A (en)
PT (1) PT80583B (en)
ZA (1) ZA854116B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862314A (en) * 1981-10-07 1983-04-13 Mazda Motor Corp Suction device of engine with supercharger
JPS5993939A (en) * 1982-11-19 1984-05-30 Toyota Motor Corp Knocking controller of internal-combustion engine
JPS6327424A (en) * 1986-07-17 1988-02-05 Shionogi & Co Ltd Sustained release pharmaceutical and production thereof
JPH07100665B2 (en) * 1987-12-23 1995-11-01 信越化学工業株式会社 Method for producing coating agent
JPH01165520A (en) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd Long acting pharmaceutical and production thereof
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5330766A (en) * 1989-01-06 1994-07-19 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
CA2007055A1 (en) * 1989-01-06 1990-07-06 Garth Boehm Theophylline dosage form
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
JPH05149118A (en) * 1991-11-29 1993-06-15 Mitsubishi Motors Corp Method of changing compression ratio of engine
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
DK0824344T3 (en) 1995-05-09 2005-08-15 Phoqus Pharmaceuticals Ltd Powdered composition for electrostatic coating of pharmaceutical substrates
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758461A1 (en) * 1997-01-17 1998-07-24 Pharma Pass PHARMACEUTICAL COMPOSITION HAVING HIGH BIOAVAILABILITY AND PROCESS FOR PREPARING THE SAME
FR2758459B1 (en) * 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
UA65607C2 (en) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Pharmaceutical composition (variants) and process for its preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (en) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
FR2796840B1 (en) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques LOW-DOSE TABLETS AND METHOD OF PREPARATION
NZ517465A (en) 1999-09-02 2003-10-31 Nostrum Pharmaceuticals Inc Controlled release pellet formulation
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
JP2002003366A (en) * 2000-06-23 2002-01-09 Freunt Ind Co Ltd Aqueous coating composition for solid medicine
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
EP2161036B1 (en) * 2007-06-06 2014-12-10 Asahi Kasei Chemicals Corporation Cellulose fine core particle, and method for production thereof
AU2012297569B2 (en) * 2011-08-16 2017-11-09 Baker Heart and Diabetes Institute Controlled-release formulation
CN107530337B (en) 2014-12-22 2021-07-09 贝克心脏与糖尿病研究所 Method of treatment

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
JPS50129727A (en) * 1974-04-04 1975-10-14
FR2313915A1 (en) * 1976-01-26 1977-01-07 Corneille Gilbert Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4180559A (en) * 1978-01-05 1979-12-25 Richardson-Merrell Inc. Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
DD146547A5 (en) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim MEDICINAL RETARDANT SHAPE WITH UNFORGETTABLE POROESEN DIFFUSION SHELLS
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
SE7813246L (en) * 1978-12-22 1980-06-23 Haessle Ab FIXED PHARMACEUTICAL PREPARATION INCLUDING BODIES WITH MULTIPLE LAYERS
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
NZ195564A (en) * 1979-11-26 1983-09-30 Sterling Drug Inc 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds
US4313951A (en) * 1979-11-26 1982-02-02 Sterling Drug Inc. 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor
DE3000979A1 (en) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach NEW DIPYRIDAMOL RETARD FORMS AND METHOD FOR THEIR PRODUCTION
DE3126703A1 (en) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach BROMHEXIN RETARD FORM AND METHOD FOR THEIR PRODUCTION
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
JPS58116414A (en) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd Composition for pharmaceutical of prolonged release containing nicardipine and preparation thereof
MX7567E (en) * 1981-12-23 1989-10-27 Yamanouchi Pharma Co Ltd PROCEDURE FOR COVERING PROLONGED NICARDIPINE
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DE3237575A1 (en) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach NEW ORAL MOPIDAMOL SHAPES
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY

Also Published As

Publication number Publication date
KR920004094B1 (en) 1992-05-25
EP0164959A2 (en) 1985-12-18
GR851356B (en) 1985-11-25
EP0164959B1 (en) 1992-03-11
NO166063C (en) 1991-05-29
ZA854116B (en) 1986-01-29
ATE73323T1 (en) 1992-03-15
US4806361A (en) 1989-02-21
DK164259C (en) 1992-10-19
JPS611614A (en) 1986-01-07
ES543826A0 (en) 1986-07-16
DK247285A (en) 1985-12-05
AU573006B2 (en) 1988-05-26
AU4323685A (en) 1985-12-12
FI87990C (en) 1993-03-25
PT80583A (en) 1985-07-01
PH24225A (en) 1990-04-10
EP0164959A3 (en) 1986-12-17
FI852235L (en) 1985-12-05
DE3585560D1 (en) 1992-04-16
DK247285D0 (en) 1985-06-03
NZ212268A (en) 1988-10-28
PT80583B (en) 1987-09-18
NO852225L (en) 1985-12-05
DK164259B (en) 1992-06-01
NO166063B (en) 1991-02-18
FI852235A0 (en) 1985-06-04
GB8414220D0 (en) 1984-07-11
CA1258232A (en) 1989-08-08
FI87990B (en) 1992-12-15
KR860000068A (en) 1986-01-25
ES8608863A1 (en) 1986-07-16
IL75403A (en) 1988-08-31

Similar Documents

Publication Publication Date Title
MX159928A (en) PROCEDURE FOR COATING DRUGS
DK136186A (en) MEDICINAL CARRIER
TR199800777T2 (en) Controlled release formulation for basic drugs of weak solubility. Controlled release formulation for basic drugs of weak solubility.
DE3579631D1 (en) MEDICINAL PRODUCTS WITH SEVERE-SOLUBLE ACTIVE SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF.
CA2282082A1 (en) Microgranules containing cisplatin
ATE119766T1 (en) PREPARATION FOR THE STOMACH.
DE3866033D1 (en) MEDICINAL PREPARATIONS WITH MICRONIZED EBSELEN CRYSTALS.
FR2638161B1 (en) NOVEL BENZOYL-2 IMIDAZO (1,2-A) PYRIDINES AND SALTS THEREOF, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NL184258C (en) PROCESS FOR PREPARING A PHARMACEUTICALLY ACCEPTABLE FORM OF THE MEDICINAL PRODUCT SODIUM 7- (D-ALFA-FORMYLOXY-ALFA-PHENYLACETAMIDO) -3- (1-METHYL-1H-TETRAZOL-5-YLTHIOMETHYL-THYL-METHYL-METHYL) AND METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION.
DE69008107D1 (en) Delayed-release preparation of a hydrochloride of a basic drug.
EP0271151A3 (en) Azumolene dosage form
ATE234608T1 (en) MICRO CAPSULES WITH DELAYED RELEASE OF ACTIVE INGREDIENTS
JPS54126722A (en) Slow release antibiotic tablet
GB9420748D0 (en) 1,5 benzodiazepine derivatives
KR19980077329A (en) Bilayer Drug-Containing Controlled Release Formulations
GR3002665T3 (en) Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host
CO4700464A1 (en) TREATMENT METHOD
TH61079A (en) Film-coated tablets for improved safety for the upper gastrointestinal tract.